Cargando…

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) represents an important health problem. At the moment, systemic therapies offered only modest clinical benefits. Thus, HCC represents a cancer extremely difficult to treat, and therapeutic breakthroughs are urgently needed. Metabolic reprogramming of ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serra, Marina, Columbano, Amedeo, Perra, Andrea, Kowalik, Marta Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696782/ https://www.ncbi.nlm.nih.gov/pubmed/33182674 http://dx.doi.org/10.3390/cancers12113318

Ejemplares similares

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
por: Kowalik, Marta Anna, et al.
Publicado: (2017)

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma
por: Serra, Marina, et al.
Publicado: (2022)

Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease
por: Kowalik, Marta A., et al.
Publicado: (2018)

Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia
por: Pal, Rajesh, et al.
Publicado: (2022)

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
por: Caddeo, Andrea, et al.
Publicado: (2021)

Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
por: Caddeo, Andrea, et al.
Publicado: (2023)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
por: Smiriglia, Alfredo, et al.
Publicado: (2023)

Induction of autophagy promotes the growth of early preneoplastic rat liver nodules
por: Kowalik, Marta Anna, et al.
Publicado: (2015)

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
por: Orrù, Claudia, et al.
Publicado: (2020)

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
por: Kowalik, Marta Anna, et al.
Publicado: (2016)

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
por: Mattu, Sandra, et al.
Publicado: (2021)

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

Editorial: Metabolism As a Therapeutic Target
por: Columbano, Amedeo, et al.
Publicado: (2017)

A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
por: Angioni, Maria Maddalena, et al.
Publicado: (2017)

Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development
por: Serra, Marina, et al.
Publicado: (2022)

Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism?
por: Serra, Marina, et al.
Publicado: (2020)

Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait
por: Trucas, Marcello, et al.
Publicado: (2023)

Unveiling the Pathogenesis of Adenomyosis through Animal Models
por: Wang, Xi, et al.
Publicado: (2022)

Animal Models of Hepatocellular Carcinoma Prevention
por: Shankaraiah, Ram C., et al.
Publicado: (2019)

Unveiling the Metabolic Changes on Muscle Cell Metabolism Underlying p-Phenylenediamine Toxicity
por: Marín de Mas, Igor, et al.
Publicado: (2017)

Advances in experimental animal models of hepatocellular carcinoma
por: Li, Jing, et al.
Publicado: (2023)

The Matrisome Genes From Hepatitis B–Related Hepatocellular Carcinoma Unveiled
por: Chen, Wei, et al.
Publicado: (2021)

Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
por: Orrù, Claudia, et al.
Publicado: (2020)

Different Effects of Regenerative and Direct Mitogenic Stimuli on the Growth of Initiated Cells in the Resistant Hepatocyte Model
por: Coni, Pierpaolo, et al.
Publicado: (1993)

Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
por: Chen, Xiaokun, et al.
Publicado: (2023)

Animal model of intrahepatic metastasis of hepatocellular carcinoma: establishment and characteristic
por: Li, Xuemei, et al.
Publicado: (2020)

Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
por: Fornari, Francesca, et al.
Publicado: (2022)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

Cardiovascular Changes in Animal Models of Metabolic Syndrome
por: Lehnen, Alexandre M., et al.
Publicado: (2013)

Unveiling the status of alien animals in the arid zone of Asia
por: Zhang, Lyubing, et al.
Publicado: (2016)

System‐level metabolic modeling facilitates unveiling metabolic signature in exceptional longevity
por: Li, Gong‐Hua, et al.
Publicado: (2022)

Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma
por: Wu, Jian
Publicado: (2016)

Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
por: Macek Jilkova, Zuzana, et al.
Publicado: (2019)

Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma
por: Du, Yong, et al.
Publicado: (2022)

REAC regenerative treatment efficacy in experimental chondral lesions: a pilot study on ovine animal model
por: Sanna Passino, Eraldo, et al.
Publicado: (2017)

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
por: De Matteis, Serena, et al.
Publicado: (2018)

Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals
por: Farazuddin, Mohammad, et al.
Publicado: (2014)

Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
por: Tsoulfas, Georgios
Publicado: (2019)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0j8dc08j08hajoat6vn07u4kh